Effects of nitric oxide and superoxide on relaxation in human artery and vein

Atherosclerosis

Volumn 133, Issue 1, 1997, Pages 77-86

  Hamilton, Carlene A ^a   Berg, Geoffrey ^b   Mcintyre, Martin ^a   Mcphaden, Allan R ^a   Reid, John L ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

Human blood vessels; Nitric oxide; Superoxide; Vascular endothelium

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CORONARY ARTERY DILATATION; CORONARY VASCULAR RESISTANCE; ENZYME ACTIVITY; FEMALE; GRAFT PATENCY; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; VEIN GRAFT;

EID: 0030818151     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00114-7     Document Type: Article

References (35)

1. Grenadine CM, Canpeau L, Thornton JC, Engle JC, Goss FS, Schreiber M. Coronary artery bypass grafting with saphenous vein. Circulation 1989;79:I24-9.
2. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with intimal-thoracic artery grafts: effects on survival over a 15-year period. New Engl J Med 1995;334:216-9.
3. Berkowitz HD, Fox A, Deaton DM. Reversed vein graft stenosis: early diagnosis and management. J Vasc Surg 1992;15:130-42.
4. Loop FD, Thomas JD. Hypoperfusion after arterial bypass grafting. Ann Thorac Surg 1993;56:812-3.
5. Kavasuji M, Tedoriya T, Takemura H, Sakakibara N, Taki J, Watanabe Y. Flow capacities of arterial grafts for coronary artery bypass grafting. Ann Thorac Surg 1993;56:957-62.
6. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium dependent relaxation in hypercholesterolaemic patients. Lancet 1993;341:1496-500.
7. Treasure CB, Klein L, Weintraub WS, Talley D, Stillabower ME, Kosunski AS, Zhang J, Boccuzzi SJ, Cedarham JC, Alexander RW. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. New Engl J Med 1995;332:481-7.
8. Matheis G, Haak T, Beyersdorf F, Baretti R, Polywka C, Winkelmann BR. Circulating endothelin in patients undergoing coronary artery bypass grafting. Eur J Cardio-Thorac Surg 1995;9:269-74.
9. Luscher TF, Diederich D, Siebenmann R, Lehmann K, Stulz P, von Segesser L, Yang Z, Turina M, Gradel E, Weber E, Buhler FR. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass graft. New Engl J Med 1988;319:462-7.
10. Clarkson PBM, Lim PO, MacDonald TM. Influence of basal nitric oxide secretion on cardiac function in man. Br J Clin Pharmacol 1995;40:299-305.
11. Joannides R, Richard V, Haefeli WE, Linder L, Luscher TF, Thuillez C. Role of basal and stimulated release of nitric oxide in the regulation of radial artery calibre in humans. Hypertension 1995;26:327-31.
12. Vallance P, Patton S, Bhagat R, MacAllister R, Radomski M, Moncada S, Malinski T. Direct measurement of nitric oxide in human beings. Lancet 1995;346:153-4.
13. Vallance P, Collier J, Moncada S. Nitric oxide synthesised from L-arginine mediates endothelium-dependent dilation in human veins in vivo. Cardiovasc Res 1989;23:1053-7.
14. Yang Z, von Segesser L, Bauer E, Stulz P, Turina M, Luscher TF. Different activation of the endothelial L-arginine and cyclo-oxygenase pathway in the human intimal mammary artery and saphenous vein. Circulation Res 1991;68:52-60.
15. Chua YL, Person PJ, Evora PRBE, Schaff HV. Detection of intra-luminal release of endothelium derived relaxing factor from human saphenous veins. Circulation 1993;88(2):128-32.
16. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin-II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest 1996;97:1916-23.
17. Inoue N, Ramasamy S, Fukai T, Nerem RM, Harrison DG. Shear stress modulates expression of Cu/Zn superoxide dismutase in human aortic endothelial cells. Circ Res 1996;79:32-7.
18. Darley-Usmar V, Radomski M. Free radicals in the vasculature: the good, the bad and the ugly. The Biochemist: Bull Biochem Soc 1994;Oct./Nov.:pp.15-8.
19. O'Hara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51.
20. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci USA 1991;88:10045-8.
21. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr D, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995;26:854-7.
22. MacAllister RJ, Calver AL, Riezebos J, Collier J, Vallance P. Relative potency and arteriovenous selectivity of nitro-vasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery. J Pharmacol Exp Ther 1995;273:154-60.
23. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989;334:997-8.
24. Garg VC, Hassid A. Nitric oxide generating vasodilators and 8 bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-7.
25. Ziche M, Morbidelli L, Granger H, Geppetti P, Ledda F. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from post-capillary venules. Biochim Biophys Res Commun 1993;192:1198-203.
26. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454-5.
27. Mugge A, Brandes RP, Boger RH, Dwenger A, Bode-Boger S, Kienke S, Frolich JC, Lichtlen PR. Vascular release of superoxide radicals is enhanced in hypercholesterolaemic rabbits. J Cardiovasc Pharmacol 1994;24:994-8.
28. Mugge A, Elwell JH, Peterson TE, Hofmayer TG, Herstad DD, Harrison DG. Chronic treatment with polyethyleneglycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol fed rabbits. Circ Res 1991;69:1293-306.
29. Hattori Y, Kawaski H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1991;261:H1086-94.
30. White RC, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, Tarpey HM. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci USA 1994;91:1044-8.
31. Garcia CE, Kilcoyne CM, Cardillo C, Cannon MRO, Quyyumi AA, Panza JA. Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertension 1995;26:863-8.
32. Garcia CE, Kilcoyne CM, Cardillo C, Cannon MRO, Quyyumi AA, Panza JA. Evidence that endothelial dysfunction in patients with hypercholesterolaemia is not due to increased extracellular nitric oxide breakdown by superoxide anions. Am J Cardiol 1995;76:1157-61.
33. Fridovich I, Handler P. Xanthine oxidase. V. Differential inhibition of the reduction of various electron receptors. J Biol Chem 1962;237:916-21.
34. Kanai AJ, Strauss HC, Truskey GA, Crews AL, Grunfeld S, Malinski T. Shear stress induced ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor. Circ Res 1995;77:284-93.
35. Sessa WC, Pritchard K, Seyedi N, Wang J, Huntze TH. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994;74:349-53.